Description of Business

6 Months Ended

Jun. 30, 2011

Description of Business

(1)  Description of Business

Neurologix, Inc. (“Neurologix” or the “Company”), is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system primarily utilizing gene therapies.  These treatments are designed as alternatives to conventional surgical and pharmacological treatments.  The Company has not generated any operating revenues and, accordingly, it is considered to be a development stage company as defined by Accounting Standards Codification (the “Codification” or “ASC”) Topic 915.